Related Experiment Video
Updated: Aug 9, 2025

12:31
Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity
Published on: May 1, 2018
13.8K
Humira: the first $20 billion drug
Jason B Gibbons1, Micaela Laber, Charles L Bennett
1Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205.
The American Journal of Managed Care
|February 22, 2023
Summary
AbbVie
Area of Science:
- Pharmaceutical market analysis
- Healthcare policy and economics
Background:
- AbbVie's adalimumab (Humira) is the world's top-selling drug.
- Government concerns over Humira spending led to a 2019 investigation into AbbVie's practices.
Approach:
- Review of US House Committee on Oversight and Accountability reports.
- Analysis of policy debates surrounding pharmaceutical pricing and market exclusivity.
Key Points:
- Incumbent manufacturers utilize strategies like patent thickets, evergreening, and Paragraph IV settlements to block competition.
- These tactics, including product hopping and linking executive compensation to sales, are prevalent in the pharmaceutical industry.
- Such practices may hinder a competitive market for essential medicines.
Conclusions:
- Legal and policy reforms are needed to curb anticompetitive behaviors in the pharmaceutical sector.
- Increased competition, particularly through biosimilars, can improve access to therapeutic options.
More Related Videos
Related Concept Videos
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
204
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
204
Prescription, Nonprescription and Orphan Drugs
810
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
810
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
226
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
226
Upper Respiratory Drugs: First and Second-Generation Antihistamines
382
Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
382
Drugs for Treatment of Ulcerative Colitis in IBD
209
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
209
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
180
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
180

